Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. (Q51315380)

3 April 2018

title

Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. (English)

1 reference

3 April 2018

main subject

steatohepatitis

0 references

transmembrane protein

0 references

cardiovascular disease

1 reference

2

1 reference

3 April 2018

Anna L. Fracanzani

4

1 reference

3 April 2018

Dorota Kaminska

8

1 reference

3 April 2018

Stefania Grimaudo

10

1 reference

3 April 2018

Tiziana Montalcini

12

1 reference

3 April 2018

Anna Alisi

13

1 reference

3 April 2018

Chao Xing

19

1 reference

3 April 2018

Bruno Dallapiccola

21

1 reference

3 April 2018

Antonio Craxì

22

1 reference

3 April 2018

Jussi Pihlajamäki

23

1 reference

3 April 2018

Lena Carlsson

26

1 reference

3 April 2018

Luca Valenti

28

1 reference

3 April 2018

Benedetta Maria Motta

Benedetta Maria Motta

7

0 references

Rosaria Maria Pipitone

Rosaria Pipitone

5

0 references

Raffaela Rametta

Raffaela Rametta

9

0 references

Enrico Mozzi

Enrico Mozzi

6

0 references

Vito Di Marco

Vito Di Marco

18

0 references

Stefano Romeo

Stefano Romeo

27

0 references

Valerio Nobili

Valerio Nobili

20

0 references

Jan Borén

16

Jan Borén

1 reference

3 April 2018

Silvia Fargion

24

Silvia Fargion

1 reference

3 April 2018

Paola Dongiovanni

1

Paola Dongiovanni

1 reference

3 April 2018

Serena Pelusi

11

Serena Pelusi

1 reference

3 April 2018

author name string

Cristina Maglio

3

1 reference

3 April 2018

Marco Maggioni

14

1 reference

3 April 2018

Vesa Kärjä

15

1 reference

3 April 2018

Pirjo Käkelä

17

1 reference

3 April 2018

Lars Sjöström

25

1 reference

3 April 2018

language of work or name

English

0 references

publication date

1 February 2015

1 reference

3 April 2018

published in

Hepatology

1 reference

3 April 2018

volume

61

1 reference

3 April 2018

issue

2

1 reference

3 April 2018

page(s)

506-514

1 reference

3 April 2018

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

cites work

1 reference

Ethnic differences in hepatic steatosis: an insulin resistance paradox?

21 January 2018

1 reference

Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.

21 January 2018

1 reference

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

21 January 2018

From fat to inflammation

1 reference

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

21 January 2018

1 reference

Carotid artery intima-media thickness in nonalcoholic fatty liver disease

21 January 2018

1 reference

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.

21 January 2018

1 reference

PNPLA3 mediates hepatocyte triacylglycerol remodeling

21 January 2018

1 reference

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk

21 January 2018

1 reference

TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content

21 January 2018

1 reference

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

21 January 2018

1 reference

Desmosterol in human nonalcoholic steatohepatitis

21 January 2018

1 reference

Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease

21 January 2018

1 reference

I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects

21 January 2018

1 reference

Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance

21 January 2018

1 reference

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis

21 January 2018

1 reference

Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia

21 January 2018

1 reference

Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits

21 January 2018

1 reference

Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity

21 January 2018

1 reference

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

21 January 2018

1 reference

Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension

21 January 2018

1 reference

Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review.

21 January 2018

1 reference

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.27490

1 reference

3 April 2018

PubMed ID

25251399

1 reference

3 April 2018